Manager × security

BNP PARIBAS FINANCIAL MARKETS XBI holdings history

SS SPDR S&P BIOTECH ETF · CUSIP 78464A870 · CIK 1166588

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, BNP PARIBAS FINANCIAL MARKETS reported 16.78M XBI (shares), valued at $2.66B, or 1.39% of its reported non-derivative portfolio. Filed 2026-08-13.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
1.39%
Shares
16.78M
16,777,726
Reported value
$2.66B
USD

Shares decreased 20.69%; reported value decreased 1.75%, and weight changed -0.39 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20261.39%16,777,726SEC filing ↗Filed Aug 13, 2026
Q1 20261.78%21,155,872SEC filing ↗Filed May 12, 2026
Q4 20251.28%16,587,354SEC filing ↗Filed Feb 10, 2026
Q3 20250.47%5,964,801SEC filing ↗Filed Nov 13, 2025
Q2 20250.49%7,610,581SEC filing ↗Filed Aug 14, 2025
Q1 20250.63%10,101,480SEC filing ↗Filed May 14, 2025
Q4 20240.83%11,884,490SEC filing ↗Filed Feb 14, 2025
Q3 20240.29%3,011,023SEC filing ↗Filed Nov 13, 2024
Q2 20240.53%5,282,303SEC filing ↗Filed Aug 13, 2024
Q1 20240.43%3,652,923SEC filing ↗Filed May 1, 2024
Q4 20230.11%701,901SEC filing ↗Filed Feb 14, 2024Amended

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20230.11%701,901$62.67MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 14, 2024
Q1 20240.43%3,652,923$346.63MShares increased 420.43%; reported value increased 453.07%, and weight changed +0.32 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 1, 2024
Q2 20240.53%5,282,303$489.72MShares increased 44.60%; reported value increased 41.28%, and weight changed +0.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2024
Q3 20240.29%3,011,023$297.49MShares decreased 43.00%; reported value decreased 39.25%, and weight changed -0.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2024
Q4 20240.83%11,884,490$1.07BShares increased 294.70%; reported value increased 259.78%, and weight changed +0.54 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20250.63%10,101,480$819.23MShares decreased 15.00%; reported value decreased 23.46%, and weight changed -0.20 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2025
Q2 20250.49%7,610,581$631.15MShares decreased 24.66%; reported value decreased 22.96%, and weight changed -0.14 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20250.47%5,964,801$597.67MShares decreased 21.62%; reported value decreased 5.30%, and weight changed -0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2025
Q4 20251.28%16,587,354$2.02BShares increased 178.09%; reported value increased 238.40%, and weight changed +0.81 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 10, 2026
Q1 20261.78%21,155,872$2.70BShares increased 27.54%; reported value increased 33.61%, and weight changed +0.50 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 12, 2026
Q2 20261.39%16,777,726$2.66BShares decreased 20.69%; reported value decreased 1.75%, and weight changed -0.39 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2026
BNP PARIBAS FINANCIAL MARKETS · SS SPDR S&P BIOTECH ETF

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1166588","quarter":"2026Q2","cusip":"78464A870"}

get_institutional_manager_history
{"cik":"1166588","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.